Arterial resections in pancreatic cancer - Systematic review and meta-analysis

HPB (Oxford). 2020 Jul;22(7):961-968. doi: 10.1016/j.hpb.2020.04.005. Epub 2020 Apr 30.

Abstract

Background: The number of pancreatic resections due to cancers is increasing. While concomitant venous resections are routinely performed in specialized centers, arterial resections are still controversial. Nevertheless they are performed in patients presenting with locally advanced tumors. Our aim was to summarize currently available literature comparing peri-operative and long-term outcomes of arterial and non-arterial pancreatic resections.

Methods: We included studies comparing pancreatic operations with and without concomitant arterial resection. Inclusion criteria were morbidity or mortality. Studies additionally reporting venous resections with no possibility of excluding this data during the extraction were discarded.

Results: The initial search yielded 1651 records. Finally, 19 studies were included in the analysis involving 2710 patients. Arterial resection was associated with a greater risk of death(RR: 4.09; p < 0.001) and complications (RR: 1.4; p = 0.01). There were no differences in the rate of pancreatic fistula, biliary fistula rate, cardiopulmonary complications, length of hospital stay and non-R0 rate. Oncologically, patients after arterial resection were at higher risk of worse 3-year survival.

Conclusion: Arterial resection in pancreatic cancer is associated with an increased risk of mortality and complications in comparison to standard non-arterial resections. Nevertheless, arterial resection may become a viable treatment for selected patients in high volume centers.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Arteries / diagnostic imaging
  • Arteries / surgery
  • Humans
  • Pancreatectomy* / adverse effects
  • Pancreatic Fistula
  • Pancreatic Neoplasms* / surgery
  • Veins